Status of advanced respiratory syncytial virus antiviral therapeutics 2025

Current Opinion in Virology · Published 2025-08-22 · DOI 10.1016/j.coviro.2025.101477

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.coviro.2025.101477

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Insights Into monoclonal antibodies and vaccines targeting respiratory viruses · Frontiers in Pediatrics · 2026 · Cites or is cited by this article
Computational Identification of Potential RSV L-RdRp Inhibitors with Predicted Superior Activity and Safety Profiles over Remdesivir Using QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations · PHARMACEUTICALS · 2026 · Cites or is cited by this article
Beyond the liver: the broadened tissue tropism of hepatitis E virus · Current Opinion in Virology · 2026 · Same journal
Molecular dialogues in plant rhabdovirus–host interactions · Current Opinion in Virology · 2026 · Same journal
New directions in the multifunctionality of RNA viruses: insights from the rabies virus P-protein · Current Opinion in Virology · 2025 · Same journal
Orthobunyavirus entry: receptors, endocytosis, and fusion cues · Current Opinion in Virology · 2026 · Same journal
Respiratory syncytial virus (RSV) and influenza A virus (IAV) interplay with the type I and III interferon (IFN) responses in the respiratory epithelium · Current Opinion in Virology · 2026 · Same journal
Virological and immunological determinants of hepatitis E virus infection outcomes · Current Opinion in Virology · 2025 · Same journal
Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy · Current Opinion in Virology · 2026 · Same journal
Inborn errors of autophagy underlying severe viral infections in humans · Current Opinion in Virology · 2026 · Same journal